Integrated CRO/CDMO Altasciences has completed acquisition of Sinclair Research, a preclinical CRO in the midwestern US. The move is designed to expand Altasciences’ reach by adding a midwest location to the company’s existing east and west coast locations.
Steve Mason, co-chief operating officer with Altasciences, said, “The number one reason we chose to acquire Sinclair was because of the dedicated and talented employees; Sinclair’s strong reputation for both customer care and quality are in line with Altasciences’ core value of providing services and solutions of the highest quality while striving to exceed expectations by truly giving our best to everything we do.”
Mason added the move Is expected to boost expertise in preclinical small-molecule development: “Altasciences’ preclinical small molecule expertise. Sinclair’s skill with conducting research on a range of drug classes will broaden our current preclinical offering and support Altasciences’ focus on providing our clients with customized solutions. Besides being a good fit in terms of culture, the site itself (located in Missouri) is in close proximity to our clinical site in Overland Park, Kansas.”